Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Propolis Extract Reduces Doxorubucin‐Induced Brain Damage by Regulating Inflammation, ER Stress, Oxidative Stress, and Apoptosis
Volkan Gelen, Mehmet Başeğmez, İnan Dursun, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 4
Open Access
Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
Sheng Zhang, Peng Wu, Jia Liu, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 87-97
Open Access | Times Cited: 27
Potential Protective Effect of Coenzyme Q10 on Doxorubicin-Induced Neurotoxicity and Behavioral Disturbances in Rats
Nilsel Okudan, Muaz Belviranlı, Tuğba Sezer
Neurochemical Research (2022) Vol. 47, Iss. 5, pp. 1280-1289
Closed Access | Times Cited: 17
Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
Vasudevan Mani, Minhajul Arfeen, Syed Imam Rabbani, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7364-7364
Open Access | Times Cited: 17
Amantadine mitigates the cytotoxic and genotoxic effects of doxorubicin in SH-SY5Y cells and reduces its mutagenicity
Solange Soares, Jayne Torres de Sousa, Fernanda Brião Menezes Boaretto, et al.
Toxicology in Vitro (2024) Vol. 99, pp. 105874-105874
Closed Access | Times Cited: 3
Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks
Sara A. Wahdan, Marwa O. El-Derany, Amany E. Abdel-Maged, et al.
Neurochemistry International (2020) Vol. 138, pp. 104777-104777
Closed Access | Times Cited: 27
N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats
Yoshihisa Kitamura, Soichiro Ushio, Yusuke Sumiyoshi, et al.
Pharmacology (2020) Vol. 106, Iss. 5-6, pp. 286-293
Closed Access | Times Cited: 27
Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo
Marwa O. El-Derany, Mohamed Noureldein
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 22
Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 105-129
Closed Access | Times Cited: 15
Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review
Rebecca P. George, Ines Semendric, Mark R. Hutchinson, et al.
Brain Behavior and Immunity (2021) Vol. 94, pp. 392-409
Closed Access | Times Cited: 20
Reductions in sleep quality and circadian activity rhythmicity predict longitudinal changes in objective and subjective cognitive functioning in women treated for breast cancer
Sonia Ancoli‐Israel, Lianqi Liu, Loki Natarajan, et al.
Supportive Care in Cancer (2021) Vol. 30, Iss. 4, pp. 3187-3200
Open Access | Times Cited: 19
Protective effect of nanocurcumin against neurotoxicity induced by doxorubicin in rat’s brain
Yasser A. Khadrawy, Eman N. Hosny, Haitham S. Mohammed
NeuroToxicology (2021) Vol. 85, pp. 1-9
Closed Access | Times Cited: 18
Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis
Medhat Taha, Sara T. Elazab, Alaa M. Badawy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 918-918
Open Access | Times Cited: 13
Diphenyl Diselenide Through Reduction of Inflammation, Oxidative Injury and Caspase-3 Activation Abates Doxorubicin-Induced Neurotoxicity in Rats
Oluwatobiloba F. Da-silva, Adedoyin R. Adelowo, Adesina A. Babalola, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 1076-1092
Closed Access | Times Cited: 2
Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats
Noha M. Mounier, Sara A. Wahdan, Amany M. Gad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 7, pp. 1537-1551
Closed Access | Times Cited: 14
Topoisomerase-Mediated DNA Damage in Neurological Disorders
Morgan Crewe, Ram Madabhushi
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Diosmin alleviates doxorubicin-induced chemobrain in rats via inhibition of oxido-inflammation, apoptosis and modulation of autophagy
Mega O. Oyovwi, Falajiki Y. Faith, Ohwin P. Ejiro, et al.
Brain Disorders (2023) Vol. 13, pp. 100111-100111
Open Access | Times Cited: 5
Mithramycin selectively attenuates DNA-damage-induced neuronal cell death
Oleg Makarevich, Boris Sabirzhanov, Taryn G. Aubrecht, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 7
Open Access | Times Cited: 13
Pilose Antler Peptide-3.2KD Ameliorates Adriamycin-Induced Myocardial Injury Through TGF-β/SMAD Signaling Pathway
Yan Xu, Xiaobo Qu, Jia Zhou, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 12
Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
Laura Boullon, Raquel Abalo, Alvaro Llorente‐Berzal
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 11
Brain network deficits in breast cancer patients after early neoadjuvant chemotherapy: A longitudinal MRI study
Jing Yang, Yongchun Deng, Daihong Liu, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 7, pp. 1138-1153
Closed Access | Times Cited: 4
NANOENCAPSULATION OF LUTEOLIN: ENHANCING BIOAVAILABILITY AND MEDICINAL BENEFITS
Bawankar Raksha, M Vaishnavi, M. Durga, et al.
International Journal of Pharmacy and Pharmaceutical Sciences (2023), pp. 1-12
Open Access | Times Cited: 4
Donepezil Ameliorates Gut Barrier Disruption in Doxorubicin-treated Rats
Kanokphong Suparan, Sirawit Sriwichaiin, Chanisa Thonusin, et al.
Food and Chemical Toxicology (2024) Vol. 189, pp. 114741-114741
Closed Access | Times Cited: 1
Role of bone marrow mesenchymal stem cell-derived exosomes in reducing neurotoxicity and depression-like behaviors induced by doxorubicin in rats
Doaa R.I. Abdel-Gawad, Fatma Khalıl, Olfat Shehata, et al.
Toxicology Research (2024) Vol. 13, Iss. 5
Closed Access | Times Cited: 1

Scroll to top